Banner with a clinician beside a large headline announcing PCOS is now PMOS and its health implications, plus a Read More button.

Published by AZ Vitality & Wellness | Women’s Hormone & Metabolic Health

Quick Answer

Polycystic ovary syndrome (PCOS) has officially been renamed polyendocrine metabolic ovarian syndrome (PMOS).

The change was published in The Lancet on May 12, 2026, after 14 years of global collaboration involving more than 56 patient and professional organizations and 22,000+ survey responses.

The new name reflects what doctors now understand: this is a complex, whole-body hormonal and metabolic condition — not simply a problem with ovarian “cysts.”

The terms PCOS and PMOS will be used interchangeably during a three-year transition period, with full adoption expected in the 2028 international guidelines.

Why Did PCOS Get a New Name?

If you’ve been recently diagnosed — or have spent years managing what you knew as PCOS — you may be wondering why the medical community changed the name now. The short version: the old name was misleading and hurting patients.

For decades, “polycystic ovary syndrome” suggested the defining feature was cysts on the ovaries. But research has shown that those aren’t true cysts at all — they’re ovarian follicles (immature eggs) that stopped developing. In fact, many people with the condition show no such follicles on ultrasound, and there is no actual increase in abnormal ovarian cysts.

Worse, the ovary-focused name framed the condition as a narrow reproductive or gynecological issue. In reality, it affects hormones, metabolism, skin, weight, mental health, and the reproductive system all at once. That mismatch between the name and the reality led to real consequences: delayed diagnoses, fragmented care, stigma, and missed chances to catch metabolic and cardiovascular risks early.

The result? An estimated 1 in 8 women worldwide — over 170 million people — live with this condition, yet up to 70% remain undiagnosed. Leaders behind the change have called the misleading name part of the problem.

What Does Polyendocrine Metabolic Ovarian Syndrome (PMOS) Actually Mean?

Breaking down the new name shows exactly why it’s a better fit:

  • Poly – many / multiple
  • Endocrine – relating to hormones and the glands that produce them
  • Metabolic – relating to how your body processes energy, including insulin and blood sugar
  • Ovarian – still acknowledging the ovarian component of the condition
  • Syndrome – a collection of related symptoms

In plain terms, PMOS leads with hormones and recognizes the metabolic dimension of the condition — the parts that the old name ignored. It signals to patients, doctors, and researchers alike that this deserves to be taken seriously as the complex, long-term health condition it is.

What Are the Symptoms of PMOS (Formerly PCOS)?

The symptoms haven’t changed — only the name and our understanding of the bigger picture. PMOS is driven by fluctuations in hormones, including disturbances in insulin and androgens, and can affect multiple body systems. Common signs include:

  • Irregular or absent menstrual periods
  • Difficulty getting pregnant or irregular ovulation
  • Excess facial or body hair (hirsutism)
  • Acne and other skin changes
  • Female-pattern hair thinning
  • Weight changes and difficulty managing weight
  • Insulin resistance and increased risk of type 2 diabetes
  • Increased cardiovascular risk
  • Mood changes, anxiety, and other effects on mental health

Importantly, these effects can persist well beyond a person’s reproductive years — another reason the old reproductive-focused framing fell short.

A note on diagnosis: The diagnostic criteria remain largely unchanged. Clinicians still look for irregular ovulation, signs of elevated androgens, and either polycystic ovaries on ultrasound or elevated anti-Müllerian hormone (AMH). If you think you may have PMOS, talk to a qualified healthcare provider for an evaluation.

Who Decided to Rename PCOS?

This wasn’t a single doctor’s decision — it was one of the largest efforts ever undertaken to rename a medical condition. The 14-year process was led by Professor Helena Teede of Monash University, alongside an international panel of clinicians, researchers, and — crucially — patients with lived experience.

The effort gathered more than 22,000 survey responses and involved over 56 patient and professional organizations, including the Endocrine Society. Notably, 86% of surveyed patients and 71% of healthcare professionals supported moving to a more accurate, symptom-based name. The new name and the science behind it were published in The Lancet and announced at the European Congress of Endocrinology in Prague.

When Does the Change Take Effect?

The name change is official now, but the rollout is gradual:

  • 2026: PMOS announced and published; awareness campaigns begin.
  • 2026–2029: A three-year transition period during which PCOS and PMOS will be used interchangeably, giving patients, providers, and health systems time to adjust.
  • 2028: Full integration into the international evidence-based guidelines used across 195 countries, with planned updates to electronic health records, medical textbooks, and the World Health Organization’s disease classification systems.

So if you see your records, lab results, or provider still using “PCOS” for a while, that’s expected and completely normal.

What Should You Do If You Have PCOS / PMOS?

First, take a breath: you don’t need to do anything urgently because of the name change. Your diagnosis is still valid, and your treatment plan doesn’t automatically change. But this is a great moment to reframe how you think about your care.

Because PMOS is a whole-body condition, the most effective approach is a comprehensive, hormone- and metabolism-focused one rather than treating symptoms in isolation. That may include:

  • Hormone evaluation and balancing to address the root endocrine drivers
  • Metabolic and insulin-resistance support, including nutrition and lifestyle guidance
  • Weight management tailored to your hormonal profile
  • Skin and dermatological care for acne and excess hair
  • Mental health and stress support, since the condition affects mood and well-being
  • Ongoing monitoring of cardiovascular and diabetes risk

This is exactly the kind of integrated, whole-person care that PMOS calls for — and it’s at the heart of what we do.

How AZ Vitality & Wellness Can Help

The PMOS name change is more than semantics — it’s validation for everyone who ever felt dismissed or told their symptoms “weren’t a big deal.” At AZ Vitality & Wellness, we’ve always treated this condition as the complex, multisystem issue it truly is.

Our team supports women navigating hormone imbalances, metabolic health, weight concerns, and the symptoms now recognized under PMOS with personalized, science-backed care. Whether you’re newly diagnosed or have been managing this for years, we’re here to help you feel like yourself again.

Ready to take the next step? Book a consultation with our team or explore our hormone and wellness services to learn how we can build a plan for your whole health.

Frequently Asked Questions

Yes. PMOS (polyendocrine metabolic ovarian syndrome) is simply the new, more accurate name for the condition formerly called PCOS (polycystic ovary syndrome). It’s the same condition, renamed to better reflect its hormonal and metabolic nature.

The old name implied the condition was mainly about ovarian cysts, which is inaccurate — there’s no real increase in abnormal cysts, and the condition affects the whole body. The new name leads with hormones and metabolism to reduce confusion, stigma, and missed diagnoses.

No. Your diagnosis remains valid, and your treatment plan does not automatically change. The diagnostic criteria are largely the same. The change mainly improves how the condition is understood and communicated.

The change was published in The Lancet on May 12, 2026, with a three-year transition period during which both names will be used.

Possibly, yes — both terms will be used interchangeably through roughly 2029 as health systems, records, and guidelines transition to the new name.

It affects about 1 in 8 women, or more than 170 million people worldwide, though up to 70% remain undiagnosed.

Medical disclaimer: This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.